For example, in these three studies, 84% (26 of 31), 100% (11 of 11), and 81% (50 of 62) NSCLC samples with truncating SMARCA4 mutations lacked BRG1 immunohistochemistry (IHC) protein expression, respectively. Here, SMARCA4 is linked to non-small cell lung carcinoma.